Clinical Trial Update: Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 ERASE trial update exploring combination therapy for persistent low-level acute myeloid leukemia after initial treatment; the study status is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Therapy-related Acute Myeloid Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Status: NOT_YET_RECRUITING